Fortress Biotech, Cyprium Tx, Sentynl Tx Announce CUTX-101 Data at 2022 ACMG
21 Mar 2022 //
GLOBENEWSWIRE
Fortress, Cyprium &Sentynl Announce the Initiation of Rolling sNDA for CUTX-101
07 Dec 2021 //
GLOBENEWSWIRE
Fortress Biotech and Cyprium Announce Positive Clinical Data for CUTX-101
08 Oct 2021 //
GLOBENEWSWIRE
Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl
24 Feb 2021 //
GLOBENEWSWIRE
Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
24 Feb 2021 //
CONTRACTPHARMA